Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 23, 2017
Pharmacy Choice - News - Generic Drugs - May 23, 2017

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/16/17 - Congressional Progressive Caucus Legislators put forth proposals to work with Trump Administration on Drug Pricing
Jan Schakowsky, D- Ill., issued the following news release:. Today, Congresswoman Jan Schakowsky, Chair of the Congressional Progressive Caucus' Health Care Task Force, led 35 of her progressive colleagues on a letter to President Donald Trump proposing an opportunity to work together to reduce the skyrocketing costs of prescription drugs.
5/16/17 - DRL LAUNCHES GENERIC HEP C DRUG
Pharmaceutical giant Dr Reddy's Laboratories has launched the generic version of Sofosbuvir and Velpatasvir fixed-dose combination under the brand name Resof Total in India. The tablets are available in bottle of count size 28. It is indicated in the treatment chronic Hepatitis C Virus, Genotype 1,2,3,4,5 or 6 infection without cirrhosis or with...
5/15/17 - BRL 2 billion worth of branded drugs forecast to lose Patent protection in five years
Since the introduction of generic drugs in 2001, Brazil's pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. The high potential of generic drugs is also driven by the fact that despite strong g
5/15/17 - Canada declared ninth biggest market for generic drugs
Generic Drugs Market growth in Canada has been catalyzed by a number of factors. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The report represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exc
5/15/17 - Congressional Progressive Caucus Legislators put forth proposals to work with Trump Administration on Drug Pricing
WASHINGTON, D.C.- Today, Congresswoman Jan Schakowsky, Chair of the Congressional Progressive Caucus' Health Care Task Force, led 35 of her progressive colleagues on a letter to President Donald Trump proposing an opportunity to work together to reduce the skyrocketing costs of prescription drugs. The letter sent today identifies specific opportuni
5/15/17 - Congressional Progressive Caucus Legislators Put Forward Proposals to Work with Trump Administration on Drug Pricing
WASHINGTON, D.C.- Today, Congresswoman Jan Schakowsky, Chair of the Congressional Progressive Caucus' Health Care Task Force, led 35 of her progressive colleagues on a letter to President Donald Trump proposing an opportunity to work together to reduce the skyrocketing costs of prescription drugs. To that end, we believe the upcoming reauthorizatio
5/15/17 - Easton Pharmaceuticals Announces Formally Accepting Proposal For The Sub-Licensing Of Product VS-Sense From German based Multi-National Pharmaceutical Company For Mexico; Agreement Includes An Up-Front Cash Payment And a Recurring Royalty
Easton Pharmaceuticals, Inc., announces that Easton/ BMV Medica have formally accepted a proposal for the sub-licensing of product VS-Sense from a German based multi-national pharmaceutical company for Mexico, which includes an upfront cash payment to Easton/ BMV and a royalty payment from all future sales. The sub-licensing agreement confirms the
5/15/17 - Generics Global Industry has increased with a CAGR of 1.4% between 2012 and 2016 and expected to increase further by 2021
Essential resource for top-line data and analysi s covering the global generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies. For the purposes of this profile, a generic is defined as a copy of an ethical drug formerly protected by patents that have now expired.
5/15/17 - Global Biosimilars and Follow-on Biologics Market 2017-2027
Monoclonal Antibodies, Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor, Interferons, Growth Hormones, Fertility Hormones. The global biosimilars and follow-on biologics market is expected to grow at a CAGR of 38.8% in the first half of the forecast period and CAGR of 11.3% in the second half of the forecast period.
5/15/17 - GW Pharmaceuticals Announces Research & Development Management Appointments
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced the appointment of Volker Knappertz, M.D. as Chief Medical Officer. Ben Whalley as Head of Discovery Research, based in the UK. Knappertz oversaw multiple regula
5/15/17 - Health and Human Services Department (HHS); Food and Drug Administration (FDA) (F.R. Page 18298) - Meeting
EVENT: Health and Human Services Department; Food and Drug Administration holds a meeting of the Oncologic Drugs Advisory Committee to discuss biologics license application 125545, for a proposed biosimilar to Amgen Inc.' s Epogen/Procrit, submitted by Hospira Inc., a Pfizer company, for the treatment of anemia. LOCATION: FDA White Oak Campus, 1090
5/15/17 - Horizon Pharma plc Announces District Court Decision to Uphold PENNSAID (diclofenac sodium topical solution) 2% w/w Patent
Horizon Pharma plc, a biopharmaceutical company focused on improving patients lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that the United States District Court for the District of New Jersey upheld the validity of Horizon Pharma s p
5/15/17 - How These Generic Drugs Stocks are Faring? Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharmacy
Pre-market today, Stock-Callers.com directs attention to Akorn Inc., Collegium Pharmaceutical Inc., Momenta Pharmaceuticals Inc., and Diplomat Pharmacy Inc.. Lake Forest, Illinois headquartered Akorn Inc.' s shares recorded a trading volume of 2.13 million shares last Friday. The stock finished the trading session 0.06% lower at $33.15.
5/15/17 - Japanese government anticipates 60% generic penetration by 2017
Japan represents the world's eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe. Historically, the lower penetration of generic drugs in Japan was due to several reasons:.
5/15/17 - Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 Market Report; Launched via MarketResearchReports.com
Market Research Reports, Inc. has announced the addition of Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022- Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs research report to their website www.MarketResearchReports.comLewes, DE 05/15/2017 Rh
5/15/17 - Teva Announces Launch of Generic Glumetza in the United States
Teva Pharmaceutical Industries Ltd., today announced the launch of generic Glumetza 1, 500 mg and 1000 mg, in the U.S.. With nearly 600 generic medicines available, Teva has the largest portfolio of FDA- approved generic products on the market and holds the leading position in first-to-file opportunities, with over 100 pending first-to-files in
5/15/17 - U.S. generic drug market witnesses growth of 13% CAGR during 2010 to 2016
The US generic drug market has witnessed a transformation over the last three decades.. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208
5/14/17 - 5 Top NASDAQ Biotech Stocks: Sangamo Gained 80.22 Percent
Last week the US Senate confirmed Scott Gottlieb as head of the US Food and Drug Administration. STAT News reported on how the massive cyberattack from last week crippled hospital networks in the UK.. Sangamo Therapeutics Durect Merus Labs International MannKind NantKwest Sangamo Therapeutics.
5/14/17 - Canada Generic Drug Market Driven by Changing Demographics and Government Initiatives
The Canada generic drug market has witnessed a significant growth over the past several years, reaching a volume of around 0.46 Billion Units in 2016. This can be attributed to public and private sector drugs programs and healthcare initiatives promoting the use of generic drugs.
5/13/17 - Analyzing Generics Market in Brazil 2017 - Research and Markets
By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Analyzing Generics Market in Brazil 2017" report to their offering. Brazil has a booming pharmaceutical market. The pharmaceutical industry in Brazil is the sixth biggest in the world in terms of value.
5/13/17 - Europe Biosimilars Market Forecast to 2025: Growing Number of Incentive Policies to Propel Growth in the Next 5-7 Years, with Oncology as the Fastest...
Europe Biosimilars Market Forecast to 2025: Growing Number of Incentive Policies to Propel Growth in the Next 5-7 Years, with Oncology as the Fastest Adopter- Research and Markets. By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the " Europe: Biosimilars Market- Forecast to 2025" r
5/13/17 - Glaxo scores again as FDA strikes down would-be Advair copycats Hikma, Vectura [Arab Finance (Egypt)]
Partners Hikma and Vectura revealed Thursday that the FDA had struck down their knockoff version of the respiratory blockbuster. Hikma and Vecturas FDA no follows one given Mylanthe only other company so far to receive a generic Advair decisionin late March. Hikma and Vectura said Thursday that the agency`s complete response letter turning back the
5/13/17 - Global Biosimilar Pipeline and Market Prospects, 2022: Addressing Production Complexities Through Risk Management and Quality by Design - Research...
Global Biosimilar Pipeline and Market Prospects, 2022: Addressing Production Complexities Through Risk Management and Quality by Design- Research and Markets. By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Global Biosimilar Pipeline and Market Prospects: Addressing Production
5/13/17 - Growth Opportunities in the Pharmaceutical PPE Market 2017-2021 - Research and Markets
By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Growth Opportunities in the Pharmaceutical PPE Market, 2016" report to their offering. This market insight covers the growth opportunities for personal protective equipment in the pharmaceutical industry. The study addresses key
5/13/17 - Insider Trading Activity Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Director Sold 7,500 shares of Stock
Insider Trading Activity For Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Richard K Prins , Director of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) reportedly Sold 7,500 shares of the company's stock at an average price of 15.43 for a total transaction amount of $115,725.00 SEC Form Insider Trading History For Amphastar Pharmaceuticals Inc (NASDAQ
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415